Navigation Links
World Health Day is April 7 with a Focus on Antibiotic Resistance
Date:4/4/2011

SAN DIEGO, April 4, 2011 /PRNewswire/ -- Antibiotics are among the most important advances in human health, but their use and misuse over the past 70 years have increased the number and types of microorganisms resistant to antibiotics – resulting in deaths, greater suffering and disability, and higher healthcare costs. For World Health Day 2011, the World Health Organization will call on governments and stakeholders to implement the policies and practices needed to prevent and counter the emergence of highly resistant microorganisms. The challenge posed to the pharmaceutical and biotechnology industries is loud and clear – only seven new antibiotics have been introduced since 2003. A press conference on April 7 will feature innovators in antibiotic research and development from industry and academia that are making strides to combat this problem.

WHAT:

Press Conference: Innovation in Antibiotics; Medicine for the Next Wave of Bacterial Infections

WHO:

Jeffrey Stein, Ph.D., President and CEO, Trius Therapeutics

Trius is focusing on the development of innovative antibiotics for life-threatening infections. Trius is in the final stage of clinical development for torezolid phosphate, a next generation antibiotic for the treatment of acute bacterial skin and skin structure infections (ABSSSI), including those caused by methicillin-resistant Staphylococcus aureus (MRSA).Trius has worked closely with FDA to define a path to market approval for antibiotics that are fast acting and with low acquisition of microbial resistance.

Daniel Burgess, President and CEO, Mpex Pharmaceuticals

Mpex is in the final stage of clinical testing of a proprietary inhalable formulation of levofloxacin for the treatment of microbial infections in patients with cystic fibrosis. The company's mission is t
'/>"/>

SOURCE Canale Communications
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Aspirin Named 8th World Wonder by Majority of Americans
3. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
4. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
5. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
6. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
11. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 ResearchMoz presents this ...  Laparoscopes Market Outlook to 2020. New report, "United States ... on the United States Laparoscopes market . The ... (in units) and average prices (in US dollars) within ... Flexible Tip Video Laparoscopes), Robotic Surgical Systems and Rigid ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new market ... Baby Food Eastern Europe 2014 ... 2014" is a new report by ERC that analyzes ... Eastern Europe , key segments, features & developments, ... examines trends which are currently affecting the industry. Furthermore, ...
(Date:8/27/2014)... 27, 2014 Sihuan Pharmaceutical Holdings Group ... a leading pharmaceutical company with the largest cardio-cerebral ... prescription drug market, today announced the ... subsidiaries (collectively the "Group") for the six months ... Financial HighlightsFor the Six months ended 30 JuneKey ...
Breaking Medicine Technology:United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7
... in non-responders to previous interferon-based therapy -, ... non- responders, with less frequent ... Annual Meeting of the American Association for the Study of Liver Diseases ... (AASLD) -, ...
... N.C., Nov. 2 /PRNewswire/,-- Fabre-Kramer Pharmaceuticals Inc. (FKP) ... the U.S. Food and Drug Administration (FDA) has ... application for gepirone extended-,release (ER) tablets, submitted for ... The FDA had previously reviewed Phase I through ...
Cached Medicine Technology:Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 2Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 5Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 6Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder 2
(Date:8/27/2014)... say knowledge is power, and a new UCLA study has ... men making the best decisions about how to treat their ... well educated about their disease have a much more difficult ... could negatively impact the quality of their care and their ... call for physicians, who can use the findings to target ...
(Date:8/27/2014)... Co-operative Research Centre into Microtechnologies, is coordinating ... innovative solutions based on microtechnologies to tackle ... life sciences, among others. IK4-Ikerlan, Ceit-IK4, IK4-Tekniker, ... with CIC microGUNE on this project, which ... Etortek 2013-2014 programme of the Government of ...
(Date:8/27/2014)... Men who eat over 10 portions a week of ... developing prostate cancer, new research suggests. , With 35,000 ... 10,000 deaths, prostate cancer is the second most common ... developed countries, which some experts believe is linked to ... following dietary and lifestyle recommendations reduces risk of prostate ...
(Date:8/27/2014)... German . There ... tumors. In case of pancreatic cancer, one of the most ... of the patients die within five years after the diagnosis. ... reduce this mortality rate. For preclinical and clinical tests of ... 5 million from investors. This will allow for the further ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Bedros Keuilian is ... in the world, the leading fitness boot camp marketing ... Gym Rescue reality series. One thing he knows very well ... a subject matter expert in the fitness business. , In ... he lays out a step-by-step instructional guide on how fitness ...
Breaking Medicine News(10 mins):Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 3Health News:Microtechnologies for driving forward mobility and human health 2Health News:Fighting prostate cancer with a tomato-rich diet 2Health News:Preclinical development of tumor therapeutic agent starts 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 3
... German . The human brain is the ... their corresponding projections, all woven together in a highly complex, ... practically insurmountable challenge to scientists. Now, however, a research team ... developed a method for tackling the mammoth task. Using two ...
... Alexandria, VA, USA The International and American Associations ... of Dental Research a study that investigated bone ... rare, primary malignant bone tumor that is more prevalent ... whether there is an association between fluoride and risk ...
... molecular medicine and genetics and of immunology and microbiology ... was awarded $1.7 million by the National Institute of ... Institutes of Health to explore how molecular elements in ... disease (NAFLD). The liver is an irreplaceable ...
... The Endocrine Society,s Journal of Clinical Endocrinology & Metabolism ... fructose corn syrup for two weeks as 25 percent of ... and triglycerides, which have been shown to be indicators of ... recommends that people consume only five percent of calories as ...
... This release is available in Spanish . ... finding breast tumors, and appears to increase a woman,s risk ... a large UC Davis study has found. The analysis ... most definitive findings to date on whether the popular mammography ...
... inherited mutations in a gene called HPRT1 lead to ... uncontrollable urges to bite their fingers, slam their arms ... mice with mutations in the same gene don,t behave ... of Medicine have identified a gene related to HPRT1, ...
Cached Medicine News:Health News:The brain's connectome -- from branch to branch 2Health News:The brain's connectome -- from branch to branch 3Health News:Study shows bone fluoride levels not associated with osteosarcoma 2Health News:NIH awards WSU researcher $1.7 million to study non-alcoholic fatty liver disease 2Health News:Fructose consumption increases risk factors for heart disease 2Health News:Popular mammography tool not effective for finding invasive breast cancer 2Health News:Gene gives clues to self-injurious behavior in rare disorder 2
... Size: 3.0 x 5.0 x 100 ... Sponge II line designed by Harvey ... is a closed cell sponge which ... soft with rounded edges to minimize ...
... Size: 2.3 x 6.4 x 80 ... Sponge II line designed by Harvey ... is a closed cell sponge which ... soft with rounded edges to minimize ...
... 5.5 x 7.5 x 80 mm. ... II line designed by Harvey A. ... a closed cell sponge which is ... with rounded edges to minimize scleral ...
... mm. Storz offers the original Scleral ... A. Lincoff, M.D. The material is ... non-toxic and non-antigenic. Implants are soft ... intrusion. These implants are packaged sterile ...
Medicine Products: